A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
MM Samama, AT Cohen, JY Darmon… - … England Journal of …, 1999 - Mass Medical Soc
Background The efficacy and safety of thromboprophylaxis in patients with acute medical
illnesses who may be at risk for venous thromboembolism have not been determined in
adequately designed trials. Methods In a double-blind study, we randomly assigned 1102
hospitalized patients older than 40 years to receive 40 mg of enoxaparin, 20 mg of
enoxaparin, or placebo subcutaneously once daily for 6 to 14 days. Most patients were not
in an intensive care unit. The primary outcome was venous thromboembolism between days …
illnesses who may be at risk for venous thromboembolism have not been determined in
adequately designed trials. Methods In a double-blind study, we randomly assigned 1102
hospitalized patients older than 40 years to receive 40 mg of enoxaparin, 20 mg of
enoxaparin, or placebo subcutaneously once daily for 6 to 14 days. Most patients were not
in an intensive care unit. The primary outcome was venous thromboembolism between days …
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely III Medical Patients
MM SAMAMA, AT COHEN, JY DARMON… - Survey of …, 2000 - journals.lww.com
SAMAMA, MEYER MICHEL; COHEN, ALEXANDER THOMAS; DARMON, JEAN-YVES;
DESJARDINS, LOUIS; ELDOR, AMIRAM; JANBON, CHARLES; LEIZOROVICZ, ALAIN;
NGUYEN, HÉLÈNE; OLSSON, CARL-GUSTAV; ALEXANDER GRAHAM TURPIE NADINE
WEISSLINGER FOR THE PROPHYLAXIS IN MEDICAL PATIENTS WITH ENOXAPARIN
STUDY GROUP
DESJARDINS, LOUIS; ELDOR, AMIRAM; JANBON, CHARLES; LEIZOROVICZ, ALAIN;
NGUYEN, HÉLÈNE; OLSSON, CARL-GUSTAV; ALEXANDER GRAHAM TURPIE NADINE
WEISSLINGER FOR THE PROPHYLAXIS IN MEDICAL PATIENTS WITH ENOXAPARIN
STUDY GROUP
以上显示的是最相近的搜索结果。 查看全部搜索结果